ABBOTT INDIA LIMITED Fair Value
ABBOTINDIA · Healthcare · Current price ₹25,970
| Method | Fair value | Status |
|---|---|---|
| Residual income | ₹5,040 | 33% ROE fading to 12% over ~20 yrs, on ₹2247 book |
| Relative P/E | ₹25,725 | EPS × 35.2 peer-median P/E |
| Graham floor | ₹6,076 | Conservative floor: √(22.5 × EPS × book value/share) |
| Analyst target | ₹33,792 | Street consensus 12-month target price |
Is ABBOTT INDIA LIMITED undervalued?
DocStoX estimates the fair value of ABBOTT INDIA LIMITED at ₹15,107 per share, versus the current market price of ₹25,970. That puts the stock about -41.8% above our fair-value estimate, which we read as "Avoid". Our confidence in this estimate is low.
How this fair value is calculated
This estimate blends 4 independent methods: Residual income (₹5,040), Relative P/E (₹25,725), Graham floor (₹6,076), Analyst target (₹33,792). We weight each by its reliability and skip any method whose inputs look untrustworthy — "no DCF beats a wrong DCF". This is the same deterministic engine that powers DocStoX stock pages; there is no guesswork or AI-generated number here.
Bear, base and bull scenarios
Our scenarios span ₹5,040 (bear) to ₹15,107 (base) to ₹33,792 (bull). A margin of safety means buying meaningfully below the base case — the wider the gap, the more room for error in the assumptions.
More on ABBOTT INDIA LIMITED
DocStoX estimates are generated by a deterministic valuation engine from reported financials — for informational purposes only, not investment advice. Consult a SEBI-registered advisor before investing.